Understanding and modifying thrombotic risk in patients with myeloproliferative neoplasms

J Cardiol. 2023 Jun;81(6):586. doi: 10.1016/j.jjcc.2022.12.009. Epub 2022 Dec 30.

Authors

Ivan Krecak¹, Anica Sabljic², Marko Lucijanic³

Affiliations

¹ Internal Medicine Department, General Hospital Sibenik, Sibenik, Croatia; Universiy of Rijeka Faculty of Medicine, Rijeka, Croatia.
² Hematology Department, University Hospital Dubrava, Zagreb, Croatia.
³ Hematology Department, University Hospital Dubrava, Zagreb, Croatia; University of Zagreb School of Medicine, Zagreb, Croatia. Electronic address: markolucijanic@yahoo.com.

PMID: 36592886
DOI: 10.1016/j.jjcc.2022.12.009

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Myeloproliferative Disorders* / complications
Neoplasms*
Thrombosis* / etiology
Thrombosis* / prevention & control